Search

Your search keyword '"Hillyer, Christopher D."' showing total 79 results

Search Constraints

Start Over You searched for: Author "Hillyer, Christopher D." Remove constraint Author: "Hillyer, Christopher D." Database Complementary Index Remove constraint Database: Complementary Index
79 results on '"Hillyer, Christopher D."'

Search Results

2. Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors.

Catalog

Books, media, physical & digital resources

4. Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats.

5. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".

6. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.

7. COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors.

8. How did we rapidly implement a convalescent plasma program?

9. Ten years of TRALI mitigation: measuring our progress.

10. Donor incentives improve cardiovascular disease risk profile and donation rates.

11. Donor incentives improve cardiovascular disease risk profile and donation rates.

12. Impact of predictive scoring model and e-mail messages on African American blood donors.

13. Storage characteristics of multiple-donor pooled red blood cells compared to single-donor red blood cell units.

14. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.

15. Evaluating a program to increase blood donation among racial and ethnic minority communities in New York City.

16. The value of area-based analyses of donation patterns for recruitment strategies.

19. Cardiovascular disease risk assessment and prevention in blood donors.

20. Demographic differences in estimated blood donor eligibility prevalence in the United States.

21. 2-(Diethylhexyl)phthalate in blood bags: is this a public health issue?

23. Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors?

24. Contribution of attitudinal factors to blood donation in African American church attendees.

25. Transfusion medicine as a profession: evolution over the past 50 years.

26. Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease

28. Effects of storage duration and volume on the quality of leukoreduced apheresis-derived platelets: implications for pediatric transfusion medicine.

29. Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index.

30. Hepatitis C Virus Prevalence and Clearance among US Blood Donors, 2006-2007: Associations with Birth Cohort, Multiple Pregnancies, and Body Mass Index.

31. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors.

32. The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral rates.

33. Consensus recommendations of pediatric transfusion medicine objectives for clinical pathology residency training programs.

34. Procedure-specific preoperative red blood cell preparation and utilization management in pediatric surgical patients.

36. Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen.

37. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients.

38. Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006.

39. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.

40. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.

41. A novel mouse model of red blood cell storage and posttransfusion in vivo survival.

42. The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells.

43. Critical evaluation of informed consent forms for adult and minor aged whole blood donation used by United States blood centers.

44. Pediatric transfusion medicine: development of a critical mass.

45. Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells.

46. The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006.

47. Transfusion recipient epidemiology and outcomes research: possibilities for the future.

48. Adverse Reactions to Allogeneic Whole Blood Donation by 16- and 17-Year-Olds.

49. Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis.

50. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A.